XML 58 R53.htm IDEA: XBRL DOCUMENT v3.19.3
SHARE-BASED PAYMENTS - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Grants in period, weighted average exercise price (in dollars per share)     $ 2.92   $ 1.75  
Number of options (in shares) 1,492,533   1,492,533   1,732,754 2,028,847
Outstanding options, weighted average exercise price (in dollars per share) $ 3.43   $ 3.43   $ 3.84 $ 4.48
Number of grants in period, net of forfeitures (in shares)     296,450   442,956  
Share-based compensation $ 710,000 $ 520,000 $ 2,500,000 $ 2,240,000    
Stock Incentive Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Common stock, shares authorized (in shares) 9,818,850   9,818,850      
Employee Stock Option            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period     2 years      
Award exercise period     5 years      
Exercisable options, weighted average remaining contractual term     3 years 2 months 16 days      
Number of grants in period (in shares)     300,000 420,000    
Number of options (in shares) 1,490,000   1,490,000      
Number of exercisable options (in shares) 1,270,000   1,270,000      
Outstanding options, weighted average exercise price (in dollars per share) $ 3.43   $ 3.43      
Exercisable options, weighted average exercise price (in dollars per share) $ 3.60   $ 3.60      
Options, vested and expected to Vest, aggregate intrinsic value $ 37,830   $ 37,830      
Restricted Stock Units (RSUs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period     3 years      
Number of grants in period, net of forfeitures (in shares)     720,000 1,190,000    
Grants in period, grant date intrinsic value (in dollars per share)     $ 2,510,000 $ 2,410,000    
Unrecognized compensation costs related to unvested stock options     $ 70,000      
Unrecognized compensation costs related to RSU awards     $ 950,000      
Share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition     2 years      
Stock Appreciation Rights (SARs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting period     5 years      
Number of grants in period (in shares)     2,200,000 0    
Grants in period, weighted average exercise price (in dollars per share)     $ 1.25      
Unrecognized compensation costs related to RSU awards     $ 1,710,000      
Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Grants in period, weighted average exercise price (in dollars per share)         $ 2.88  
Outstanding options, weighted average exercise price (in dollars per share) $ 15.61   $ 15.61   $ 15.61 $ 15.61
Maximum | Employee Stock Option            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Exercisable options, weighted average remaining contractual term     10 years      
Share-based Compensation Award, Tranche One | Stock Appreciation Rights (SARs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Grants in period, weighted average exercise price (in dollars per share)     $ 5.00      
Period of exercise price     90 days      
Share-based Compensation Award, Tranche Two | Stock Appreciation Rights (SARs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Grants in period, weighted average exercise price (in dollars per share)     $ 7.00      
Period of exercise price     90 days      
Share-based Compensation Award, Tranche Three | Stock Appreciation Rights (SARs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Grants in period, weighted average exercise price (in dollars per share)     $ 10.00      
Common Stock | Stock Appreciation Rights (SARs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Grants in period, weighted average exercise price (in dollars per share)     $ 2.92